By Dr. Kamran Ali, Thoracic Surgeon
Introduction
A diagnosis of lung cancer can change your whole world. There are so many questions, worries, and urgency to find clarity. An important first step after someone has been diagnosed with lung cancer is the step of staging. Understanding Lung Cancer Staging provides both doctor and patient with context for the disease – where it started, where it has spread, and the options for treatment that are the most relevant.
In this article, we will describe in depth what Lung Cancer Staging means, how we stage the disease, and why Lung Cancer Staging is so significant in the treatment planning process. Regardless of whether you’re the newly diagnosed or caring for someone who is navigating this complex condition, this guide serves as a resource for understanding the process of lung cancer staging with an informed and confident perspective.
What Is Lung Cancer Staging?
Staging Lung Cancer is the determination of how much cancer is in the body and how far it has spread. Staging enables doctors to understand both the extent of the disease, which organs or lymph nodes are affected, and whether the disease has spread beyond the lungs.
The purpose of staging the cancer is to answer the following three key questions:
1. Where is the primary tumor?
2. Has the cancer spread to nearby lymph nodes?
3. Has the cancer spread to distant places (metastatic)?
If these are determined your doctor can derive the most effective plan for treatment, whether surgery, chemotherapy, radiation, immunotherapy, or some combination of all these approaches.
Why Is Lung Cancer Staging So Important?
To patients, Lung Cancer Staging is not a medical concept — it establishes a roadmap for any subsequent decision. It determines:
• Treatment Options: Whether surgical options are feasible or if non-surgical treatments are deemed more effective.
• Prognosis: It gives you an idea of the expected outcome and survival statistics.
• Clinical Trials: Many clinical studies or new therapies have patients enrolled in a certain cancer stage.
• Communication: It allows doctors across many health care systems from around the world to discuss each treatment, using the same terms, and for hospitals to compare those treatment outcomes.
Types of Lung Cancer
Before we cover further details about Lung Cancer Staging, it’s important to note that lung cancer is not a single disease. Lung cancer is primarily divided into two main categories:
1. Non-Small Cell Lung Cancer – this is the most common, approximately 85% of lung cancers fall into this category, some of the subtypes include,
- Adenocarcinoma
- Squamous Cell Carcinoma
- Large Cell Carcinoma
2. Small Cell Lung Cancer – this is more aggressive and spreads quicker than non-small cell lung cancer and it accounts for approximately 10% to 15% of lung cancers.
Both types have different staging systems, but the principles are largely the same.
How Is Lung Cancer Staging Done?
Staging consists of a series of tests, scans, and occasionally minor procedures. It may seem complicated, but every step eventually leads to information that helps develop an accurate picture.
1. Tests with Imaging
These are used to find the tumor and determine if it has spread:
• CT (Computed Tomography) Scan: Provides detailed cross-sectional images of the chest and abdomen.
• PET (Positron Emission Tomography) Scan: Shows areas of active cancer cell throughout the body.
• MRI (Magnetic Resonance Imaging): Used frequently to determine if there is brain metastasis.
• Bone Scan: Shows if cancer has gone to the bones.
2. Biopsy and Pathology
Looking at a sample of the tumor establishes that the tumor is cancer and sometimes can provide additional molecular information that helps determine treatment. Some methods to obtain tissue are:
• Bronchoscopy: A camera-tipped tube goes through the airway to visualize and biopsy tissue from the area of suspicion.
• CT-guided Needle Biopsy: Uses imaging to obtain a sample from a lung mass.
• Mediastinoscopy: Permits biopsy of lymph nodes located in the chest.
3. Surgical Assessment
Sometimes surgery alone serves the purposes of determining the extent of disease spread, especially the lymph nodes.
4. Molecular and Genetic Testing
Newer testing seeks to identify specific mutations (most commonly EGFR, ALK, KRAS mutations) that can be targeted with precision therapies — a major component of planning lung cancer treatment in 2022.
The TNM System of Lung Cancer Staging
The stage of lung cancer is most commonly estimated by the TNM classification established by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC). The letters represent different aspects of the disease: ‘T’ represents the size and location of the primary tumor, ‘N’ indicates whether the cancer has spread to nearby lymph nodes, and ‘M’ indicates whether the cancer has spread to distant organs. Each of these components has its own numerical grading, and the overall stage is determined by the combination of the components.
T – Tumor (Primary Site)
| Category | Description |
| T1 | Tumor ≤3 cm, confined to one lobe of the lung |
| T2 | Tumor >3 cm but ≤5 cm or involves nearby structures like the main bronchus |
| T3 | Tumor >5 cm but ≤7 cm or invades nearby structures such as the chest wall |
| T4 | Tumor >7 cm or invades major organs (heart, trachea, esophagus) or has multiple nodules in the same lobe |
N – Nodes (Lymph Node Involvement)
| Category | Description |
| N0 | No lymph node involvement |
| N1 | Spread to nodes within the lung or near the bronchi |
| N2 | Spread to mediastinal or subcarinal lymph nodes (mid-chest) |
| N3 | Spread to lymph nodes on the opposite side of the chest or neck |
M – Metastasis (Spread to Other Organs)
| Category | Description |
| M0 | No distant metastasis |
| M1a | Cancer in the opposite lung or in the fluid around the lung/heart |
| M1b | Single distant metastasis (one organ site) |
| M1c | Multiple distant metastases (multiple organs) |
Lung Cancer Staging Chart (Stage I to IV)
Once the TNM classifications are made, they are placed into greater overall stages (Stage 0 – Stage IV).
Stage 0 (Carcinoma in situ)
• The cancer is located only in the top layer of the lining of the lung.
• There is no invasion into deeper levels of tissue.
• Very curable with surgery to remove.
Stage I
• The cancer is still located in the lung, and there is no nodal involvement.
• Treated with surgery, and sometimes followed by chemotherapy.
• Has a very favorable prognosis if completely resected.
Stage II
• The tumor may be larger, or have lymph nodes involved in close proximity.
• Surgery typically can still be an option, but chemotherapy or radiation can follow.
Stage III
• The cancer has also spread to lymph nodes in the mediastinum or possible nearby structures.
• Treatment usually requires combination therapy – chemotherapy, radiation, and sometimes surgery.
• Split into IIIA, IIIB, IIIC depending on pattern of spread.
Stage IV
• At this stage, cancer has spread to distant organs such as the brain, liver, adrenal glands, or bones.
• Surgery is typically not an option, but targeted therapies or immunotherapies or advanced medications can help with disease control and improve quality of life.
Lung Cancer Staging for Small Cell Lung Cancer (SCLC)
In contrast to the TNM system used for non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC) is typically classified as one of two major stages:
– Limited Stage: Cancer is confined to one lung, nor to nearby and accessible nodes (ie, can be treated with an appropriate radiation field).
– Extensive Stage: Cancer has spread to the other lung, or or has metastasized to distant sites and major organs.
All patients with SCLC will be more readily identified using this binary approach. It makes the decision-making approach for chemotherapy and radiation therapy much simpler.
Modern Advances in Lung Cancer Staging
Due to improvements in imaging and molecular science, Lung Cancer Staging is now more precise than ever before:
– Metabolic and anatomical information is combined using a PET-CT scan that improves accuracy.
– Real-time lymph node biopsies are done with minimal invasion using Endobronchial Ultrasound (EBUS).
– Molecular markers help us fine-tune both staging and treatments – some patients with “Stage IV” lung cancer respond so effectively to targeted therapy that their outcomes have an early stage appearance.
Dr. Kamran Ali would emphasize how position technologies contribute to patient-centered approaches in lung cancer treatment so the patient can get the best, least invasive treatment possible.
Emotional and Practical Aspects of Staging
The concept of “stages” can be daunting. Many patients automatically think a higher stage is synonymous with hopelessness — this is not the case. Lung Cancer Staging is simply a guideline, and not a death sentence.
Current medicine has changed how we approach lung cancer management:
• Patients with Stage IV disease are living longer than ever because of both targeted therapy and immunotherapy.
• What was previously Stage III cancers and only treatable with radiation, are now sometimes surgically treatable following systemic treatment (pre-treatment).
• Early identification through screening (i.e. low-dose CT scan) has aided in the cure of Stage I cancers.
Knowing your stage is empowering — it helps you and your medical team elicit clear and informed decisions.
How Doctors Discuss Lung Cancer Staging with Patients?
Dr. Kamran Ali advocates clear and compassionate communication. If he is discussing Lung Cancer Staging, he always makes sure patients are aware of the following:
• What the stage refers to: in plain terms, with some images or scan representations.
• What treatment options may be available: including goals and potential side effects.
• What can be expected: both with regards to longevity and quality of life.
He encourages people to bring family, ask questions, and take notes during appointments. He believes that knowledge and support are key in coping with the diagnosis.
Frequently Asked Questions About Lung Cancer Staging
- Can the stage of lung cancer change after surgery or treatment?
Yes, the clinical stage based on scans may be different from the pathological stage which was obtained after surgery. Surgery provides the most accurate information about tumor size and whether it has spread to the lymph nodes or not.
- Does Stage IV lung cancer mean death?
Not necessarily. A large number of patients live with Stage IV lung cancer for years because of targeted therapy and immunotherapy. Stage IV is oftentimes being treated like a chronic disease.
- Does staging differ between smoker’s vs non-smokers?
The lung cancer staging system does not differ between smoker’s vs non-smokers. However, the underlying biological behavior of the tumor and response to treatment may differ according the genetics of the tumor.
- How soon is staging done after a diagnosis?
Usually, staging is completed within a few days to a couple of weeks. Getting staging done quickly helps doctors make treatment decisions more rapidly which is important for the aggressive nature of lung cancer.
- If lung cancer is diagnosed in early stage, can it come back?
Yes, lung cancer can come back, but imaging and follow up can often identify recurrent disease quickly. Surveillance plans and therapy options are personalized for each patient.
Living with Lung Cancer – Hope and Healing
Although the staging process may feel clinical, it is a necessary component of a holistic process including emotional healing, lifestyle changes, and support.
Patients are supported to:
• Keep moving per the recommendations of their care team.
• Eat a protein-rich diet with a balanced nutritional plan to keep strength.
• Engage in support groups to help with emotional healing.
• Eliminate smoking and secondhand smoke exposure completely.
Dr. Kamran Ali and his team at [Max Super Specialty Hospital] embrace a holistic approach focusing on not only eliminating the tumor, but also enhancing quality of life beyond treatment.
Conclusion
Lung Cancer Staging is the foundation of lung cancer care. It tells the story of the extent of disease progression – but perhaps more importantly, it lays the path forward.
The advancements in diagnostics, precision medicine and compassion are at an all-time high, so patients with lung cancer today have more hope today than ever. Regardless of the stage at diagnosis, every patient deserves individualized attention, knowledge and assurance throughout their treatment journey.
If you or someone you care for has being diagnosed with lung cancer, it is important to speak with an experienced thoracic surgeon like Dr. Kamran Ali, who will provide surgical expertise and patient care while guiding you along this journey.
